Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Keeping Track: Novartis, Calardius Pick Up Speed; ADMA Stumbles

Aug 05 2016

• By Michael Cipriano

Related Content

Biosimilars Still Flummoxed By Neulasta: Sponsors Now 0 For 2 At FDA

Jul 19 2016

Manufacturing Problems Aren't Rising, But It Was A Hot July

Jul 30 2016

Keeping Track: FDA Approves Adlyxin, Accepts Brineura, Lowers Hurdle For Xadago

Jul 29 2016

AstraZeneca Diabetes Combo Needs More Clinical Data, FDA Says

Oct 16 2015

Meek To Drive M&A At Ipsen, Building On Two Major Launches

Aug 01 2016

Related Companies

ADMA Biologics, Inc.

Natco Pharma Limited

Roche Holding AG

Gilead Sciences, Inc.

Novartis AG

Lisata Therapeutics, Inc.

Bausch Health Companies Inc.

Ocular Therapeutix, Inc.

Alvogen, Inc.

Novartis AG

Amgen, Inc.

Johnson & Johnson

Genmab A/S

Merck & Co., Inc.

Sumitomo Pharma Co., Ltd.

Boehringer Ingelheim GmbH

AstraZeneca PLC

AstraZeneca PLC

Samsung Bioepis Co., Ltd.

Sanofi

Additional Topics

United States Approvals Drug Review Drug Approval Standards Regulation BioPharmaceutical

More from Approvals

More from Product Reviews

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.